**Question:** All of the following drugs cause hemolysis with G-6-PD deficiency except -

A. Sulfa drugs (e.g., sulfamethoxazole, trimethoprim)
B. Quinine
C. Phenazopyridine
D. Glucose-6-phosphate dehydrogenase (G-6-PD) is an enzyme involved in the breakdown of drugs like sulfa drugs and red blood cell destruction.

**Core Concept:** Glucose-6-phosphate dehydrogenase (G-6-PD) is an enzyme that plays a crucial role in the red blood cell's antioxidant defense system. It is involved in the breakdown of certain medications, primarily sulfa drugs. Hemolysis occurs when the patient's red blood cells lack sufficient G-6-PD activity, leading to their destruction.

**Why the Correct Answer is Right:**
Drugs like sulfa drugs (e.g., sulfamethoxazole, trimethoprim), on the other hand, cause hemolysis in G-6-PD deficient individuals due to their inherent properties. Sulfa drugs are known to be substrates for G-6-PD, meaning they are oxidized by the enzyme, generating reactive oxygen species (ROS) which can damage the red blood cells and lead to hemolysis.

**Why Each Wrong Option is Incorrect:**

A. Sulfa drugs are substrates for G-6-PD, which generates reactive oxygen species (ROS) leading to hemolysis in G-6-PD deficient individuals. Quinine is not a sulfa drug and does not have this mechanism of action, making it safe in G-6-PD deficient individuals.

B. Quinine belongs to the group of antimalarial medications and does not directly cause hemolysis by generating ROS in G-6-PD deficient individuals.

C. Phenazopyridine is a urinary analgesic and anti-inflammatory agent, which does not involve the G-6-PD enzyme in its mechanism of action. It does not cause hemolysis in G-6-PD deficient individuals.

D. Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency can lead to hemolysis upon exposure to certain drugs. However, glucose-6-phosphate dehydrogenase deficiency does not affect the mechanism of action of glucose-6-phosphate dehydrogenase itself, making glucose-6-phosphate dehydrogenase deficiency a risk factor for hemolysis induced by certain drugs, not a cause of hemolysis.

**Clinical Pearl:** Glucose-6-phosphate dehydrogenase deficiency is a genetic disorder affecting the enzyme glucose-6-phosphate dehydrogenase, which plays a crucial role in the antioxidant defense system of red blood cells. The deficiency itself does not cause hemolysis, but patients with G-6-PD deficiency are at increased risk of hemolysis upon exposure to certain drugs. For example, sulfonamides (sulfa drugs) and antimalarial agents like primaquine and chloroquine are known to cause hemolysis in G-6-PD deficient individuals due to their ability to react with the oxidized form of the enzyme and generate reactive oxygen species (ROS), leading